Market Research Logo

Olink Proteomics AB - Product Pipeline Analysis, 2018 Update

Olink Proteomics AB Company Overview
Olink Proteomics AB Company Snapshot
Olink Proteomics AB Pipeline Products and Ongoing Clinical Trials Overview
Olink Proteomics AB – Pipeline Analysis Overview
Olink Proteomics AB - Key Facts
Olink Proteomics AB - Major Products and Services
Olink Proteomics AB Pipeline Products by Development Stage
Olink Proteomics AB Pipeline Products Overview
Blood Test - Diagnostic Purposes
Blood Test - Diagnostic Purposes Product Overview
cJun-Smad 2/3 Kit
cJun-Smad 2/3 Kit Product Overview
Companion Diagnostic Assay - Aromatase
Companion Diagnostic Assay - Aromatase Product Overview
Companion Diagnostic Assay - Trastuzumab
Companion Diagnostic Assay - Trastuzumab Product Overview
HER2-pEGFR Kit
HER2-pEGFR Kit Product Overview
s100A4 Kit
s100A4 Kit Product Overview
Olink Proteomics AB - Key Competitors
Olink Proteomics AB - Key Employees
Olink Proteomics AB - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Olink Proteomics AB, Recent Developments
Dec 14, 2017: Olink Proteomics announces the availability of the most comprehensive, high-multiplex protein biomarker panel for mouse studies
Feb 16, 2017: Olink Proteomics announces the availability of three new biomarker panels focused on key biological processes with broad clinical relevance
Nov 29, 2016: Olink Proteomics announces the availability of three new biomarker panels to further explore the complexities of the human proteome
Sep 21, 2016: Olink Proteomics announces the availability of the broadest and most complete protein biomarker panel for immuno-oncology
Apr 12, 2016: Focusing for success: A new Olink company organization to meet our future ambitions
Oct 06, 2015: Olink Bioscience introduces two new 92 - protein biomarker panels for cardiovascular disease research
Jul 01, 2014: Olink Bioscience introduces a 92 - protein biomarker panel for inflammatory diseases
Oct 29, 2013: Olink Bioscience introduces a 92 protein biomarker panel for cardiovascular disease
Mar 12, 2013: Olink Bioscience Introduces Scalable Protein Biomarker Assays with Proseek Multiplex
Sep 14, 2011: Olink Appoints New CEO and Expands Board of Directors
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Olink Proteomics AB Pipeline Products and Ongoing Clinical Trials Overview
Olink Proteomics AB Pipeline Products by Equipment Type
Olink Proteomics AB Pipeline Products by Indication
Olink Proteomics AB, Key Facts
Olink Proteomics AB, Major Products and Services
Olink Proteomics AB Number of Pipeline Products by Development Stage
Olink Proteomics AB Pipeline Products Summary by Development Stage
Blood Test - Diagnostic Purposes - Product Status
Blood Test - Diagnostic Purposes - Product Description
cJun-Smad 2/3 Kit - Product Status
cJun-Smad 2/3 Kit - Product Description
Companion Diagnostic Assay - Aromatase - Product Status
Companion Diagnostic Assay - Aromatase - Product Description
Companion Diagnostic Assay - Trastuzumab - Product Status
Companion Diagnostic Assay - Trastuzumab - Product Description
HER2-pEGFR Kit - Product Status
HER2-pEGFR Kit - Product Description
s100A4 Kit - Product Status
s100A4 Kit - Product Description
Olink Proteomics AB, Key Employees
Olink Proteomics AB, Other Locations
Olink Proteomics AB, Subsidiaries
Glossary
List of Figures
Olink Proteomics AB Pipeline Products by Equipment Type
Olink Proteomics AB Pipeline Products by Development Stage

Summary

Olink Proteomics AB (Olink) is a biotechnology company that offers products and services for human protein biomarker research. The company provides portfolio of products such as biomarkers, cardiovascular diseases panels, neurological disease panels, inflammation panels and oncology panels. Olink through its Proximity Extension Assay (PEA) technology develops multiplex immunoassay panels for human protein biomarker research. It works in collaboration with other organizations to develop new projects. The company through Olink Bioscience focuses on the development and commercialization of enabling molecular tools for life science research and molecular diagnostics. It also provides protein biomarker discovery data analysis services in Watertown and Sweden. The company also has operational presence in the US. Olink is headquartered in Uppsala, Sweden.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Olink Proteomics AB
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;